Clinical trial

A Study to Investigate the PK and Safety of CKD-393

NCT04768673

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-26

PhasePHASE1

Study timeline

Study start (actual)2021-03-26Date precision: day

Registry last updated2021-08-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type II Diabetesunresolved

Interventions

CKD-393 formulation IDRUG

CKD-393 formulation IIDRUG

D501, D759, H053DRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04768673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.